Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > TH's website issues

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Apr 25, 2021 5:46pm

113 Views

Post# 33064212

RE:RE:RE:RE:RE:RE:RE:RE:RE:TH's website issues

I agree. Let's just let Wino handle this however he thinks best.

palinc2000 wrote:
I dont think having them agree to a wrtten summary of the meeting is s good idea ....
Creating a sense of legal liability is not the way to have an open , frank discussion ... on the contrary !

scarlet1967 wrote:

I am not overly optimistic but since you have made the effort I would like to point out few things although you probably know:

1-You are not as good as they you are BETTER.

2-It seems you have already prepared your pitch with few requests, don’t let them bargain it is NOT a negotiation.

3-You can elaborate on your requests but most of the conversation should be about their responses.

4-Stay on topics don’t let them distract you from the purpose of the meeting.

5-If they can’t present solid plans to address the issues schedule another meeting as soon as possible so the company can respond with concrete solutions.

6-Leave the door open for future conversations so the company can interact with the shareholders on an ongoing basis.

5-Ideally everything should be in writing but since this is an informal meeting it would be a good idea if you could draft a summary of the meeting and email it back to the company for their review/approval before reporting back to the investors so there is an element of liability to the whole exercise.

Wino115 wrote: The only person I contacted was Paul. Although, I have noticed a ton of people with familiar names pinged my LinkedIn.

Bucknelly21 wrote:

great who contacted you wino?